ORAGENICS, INC. Restricted Cash, Current
ORAGENICS, INC. (OGEN) had Restricted Cash, Current of $1.41 million as of 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Balance Sheet › Assets › Assets, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2017-10-31
- 2017-09-30: Restricted Cash, Current $1.41M.
- 2017-06-30: Restricted Cash, Current $1.92M.
| Period end | Restricted Cash, Current |
|---|---|
| 2017-09-30 | $1.41M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.92M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |